Arthritis associated with calcium oxalate crystals in an anephric patient treated with peritoneal dialysis.
We report a case of calcium oxalate arthropathy in a woman undergoing intermittent peritoneal dialysis who was not receiving pharmacologic doses of ascorbic acid. She developed acute arthritis, with calcium oxalate crystals in Heberden's and Bouchard's nodes, a phenomenon previously described in gout. Intermittent peritoneal dialysis may be less efficient than hemodialysis in clearing oxalate, and physicians should now consider calcium oxalate-associated arthritis in patients undergoing peritoneal dialysis who are not receiving large doses of ascorbic acid.
Rosenthal
A
A
Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.
Ryan
L M
LM
McCarty
D J
DJ
D000368:Aged; D001168:Arthritis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000378:metabolism; D001205:Ascorbic Acid / Q000009:adverse effects; D002129:Calcium Oxalate / Q000378:metabolism*; D003460:Crystallization; D005260:Female; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D010530:Peritoneal Dialysis; D011859:Radiography
D002129:Calcium Oxalate; D001205:Ascorbic Acid